NetworkNewsBreaks – Zenosense, Inc. (ZENO) MIDS
Post# of 53
(Total Views: 140)
Posted On: 09/05/2018 6:51:16 PM
NetworkNewsBreaks – Zenosense, Inc. (ZENO) MIDS Medical Ltd. JV Secures Up to $1.2M in Staged Funding
Zenosense (OTC: ZENO), a healthcare technology company, this morning announced that its MIDS Medical Ltd. (“MML”) joint venture (“JV”) has entered a staged funding for the next phase of development of the MIDS Cardiac™ hand-held technology. MML entered into an agreement with a third-party investor for funding of up to a total of $1,200,000 on August 31, 2018. The funding is anticipated to cover the expenses of the next key development phase intended to prove that the MIDS magnetic detection method can detect and accurately quantify a live high sensitivity (“HS”) assay on the MIDS microfluidic test strip. Per the agreement, MML will receive an initial total amount of $300,000 in exchange for ordinary shares in MML representing a 2.91% equity ownership, with the option to make scheduled payments up to an additional $900,000. The full $1,200,000 investment would result in a 10.31% equity ownership in MML.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Zenosense (OTC: ZENO), a healthcare technology company, this morning announced that its MIDS Medical Ltd. (“MML”) joint venture (“JV”) has entered a staged funding for the next phase of development of the MIDS Cardiac™ hand-held technology. MML entered into an agreement with a third-party investor for funding of up to a total of $1,200,000 on August 31, 2018. The funding is anticipated to cover the expenses of the next key development phase intended to prove that the MIDS magnetic detection method can detect and accurately quantify a live high sensitivity (“HS”) assay on the MIDS microfluidic test strip. Per the agreement, MML will receive an initial total amount of $300,000 in exchange for ordinary shares in MML representing a 2.91% equity ownership, with the option to make scheduled payments up to an additional $900,000. The full $1,200,000 investment would result in a 10.31% equity ownership in MML.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Zenosense Inc. (ZENO) Stock Research Links
Scroll down for more posts ▼